MASTERPLAN
17 Dec 2020
MASTERPLAN
ACTRN12619000409178
A Randomised Phase II Study of MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease (MASTERPLAN)
NHMRC
Cancer Type | Pancreas |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2019-08-30 |
Anticipated End Date | - |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Professor Hien Le |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs